This award funds highly creative scientists to pursue groundbreaking, high-risk research that could transform key areas of science related to the NIH mission.
This award funds creative early-stage researchers proposing innovative, high-impact projects in any NIH-relevant field, as part of NIH’s High-Risk, High-Reward Research Program.
This grant funds innovative, high-impact research projects aiming to transform understanding or treatment of Down syndrome and its related conditions, without requiring preliminary data.
This award funds exceptional early-career researchers to launch independent NIH-relevant projects immediately after doctoral or clinical training, bypassing the typical postdoctoral phase.
NIH's R21 grant supports early-stage, high-risk clinical trial research with potential for breakthroughs in biomedical, behavioral, or clinical fields.